Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Bone graft & orthobiologics · Maryland | Bone graft & orthobiologics · Texas | |
|---|---|---|
| Surgeons, 2024 | 14 | 52 |
| Medicare fee-for-service cases | 451 | 1,980 |
| Growth since 2019 (Medicare FFS) | −8%/yr | −11%/yr |
| Forecast cases (Medicare FFS) | 370 in 2030 | 1,960 in 2030 |
| Forecast growth | −3.3%/yr to 2030 | −0.1%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.5 | 0.9 |
| Medicare Advantage share | 28% | 59% |
| Out of hospital | 4% (+3 pts since 2019) | 3% (+2 pts since 2019) |
| Cases per surgeon | 32 | 38 |
| Top 10 surgeons' share | 86% | 40% |
| Surgeons growing | 1 | 1 |
| New since the base year | 2 | 7 |
| Likely to stop billing it | 6 by 2026 | 9 by 2026 |
| Forecast miss, 1 year (procedure) | 12% | 12% |
| Company payments per surgeon | $7,717 | $9,010 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.